Valuation: Haemonetics Corporation

Market Cap 3.89B 3.38B 3.15B 2.89B 5.45B 371B 5.54B 37.08B 14.55B 185B 14.6B 14.28B 619B P/E 2027 *
21.7x
P/E 2028 * 19.2x
Enterprise Value 4.56B 3.96B 3.69B 3.39B 6.4B 435B 6.5B 43.49B 17.07B 217B 17.13B 16.75B 727B EV / Sales 2027 *
3.25x
EV / Sales 2028 * 2.9x
Free-Float
98.74%
Yield 2027 *
2.34%
Yield 2028 * -
1 day+0.85%
1 week+8.58%
1 month+14.28%
3 months+44.35%
6 months+28.32%
Current year+6.72%
1 week 79.35
Extreme 79.35
85.71
1 month 71.81
Extreme 71.81
85.71
Current year 51
Extreme 51
86.11
1 year 47.32
Extreme 47.315
87.32
3 years 47.32
Extreme 47.315
97.97
5 years 43.5
Extreme 43.5
97.97
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 16/05/2016
Director of Finance/CFO 55 11/04/2022
Chief Operating Officer 56 01/04/2025
Director TitleAgeSince
Director/Board Member 73 01/01/2006
Director/Board Member 62 16/05/2016
Director/Board Member 71 18/10/2017
Date Insider Type Main position Quantity % Market Cap.
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
24/7/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+8.58%+14.40%-7.28% 3.89B
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
Average +1.54%+5.16%+9.37%+2.04% 56.51B
Weighted average by Cap. +0.92%+3.46%-0.00%+4.15%

Financials

2027 *2028 *
Net sales 1.4B 1.22B 1.13B 1.04B 1.97B 134B 2B 13.37B 5.25B 66.62B 5.26B 5.15B 223B 1.47B 1.28B 1.19B 1.1B 2.07B 141B 2.1B 14.06B 5.52B 70.06B 5.54B 5.41B 235B
Net income 176M 153M 143M 131M 247M 16.84B 251M 1.68B 660M 8.38B 662M 648M 28.11B 204M 177M 165M 151M 286M 19.46B 290M 1.94B 763M 9.69B 765M 749M 32.48B
Net Debt 672M 585M 544M 500M 943M 64.19B 958M 6.41B 2.52B 31.96B 2.53B 2.47B 107B 385M 335M 311M 286M 540M 36.73B 548M 3.67B 1.44B 18.29B 1.45B 1.41B 61.32B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
31/07/26 US$85.54 +0.85% 789,607
30/07/26 US$84.82 -0.70% 555,195
29/07/26 US$85.42 +3.49% 893,444
28/07/26 US$82.54 +3.29% 803,456
27/07/26 US$79.91 +1.43% 803,181
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
85.54USD
Average target price
87.90USD
Spread / Average Target
+2.76%

Quarterly revenue - Rate of surprise